pixel2


Annual Review 2015

30 years closer to a cure

Together, we are capable of extraordinary things, and together, I have no doubt we will achieve them.

2015 has proved to be an outstanding year for the Institute. We have not only maintained our positive trajectory towards achieving our strategic goals, but have accelerated it, with many long-term plans coming to fruition. Individually and collectively, our people have stretched themselves further than ever to deliver outstanding results. Most satisfying of all, we are seeing those results directly translating into improved outcomes for children with cancer.

Our 2015 highlights include:

  • We are playing a central role in Australia's first personalised mdicine program for children with cancer, the Zero Childhood Cancer Program
  • We forged a valuable new partnership with the Peter MacCallum Cancer Centre, which will see our two Institutes combine forces to create this country's first-ever childhood cancer immunotherapy program.
  • We are synchronising our efforts with The Sydney Children's Hospitals Network Research Institute through the translational research partnership 'Paediatrio'
  • The 'Paediatrio' was awarded an extremely generous capital grant from the NSW State Government.
  • We were able to continue our partnership with CRC for Cancer Therapeutics (CTx), which has funded key appointments in our Zero Childhood Cancer Program.
  • The Centre for Childhood Cancer Research, jointly established with UNSW last year, is now 'open for business' and our PhD Candidates are being enrolled through the Centre.
  • Professors Richard Lock and Maria Kavallaris were awarded a new Program Grant by the NHMRC
  • We achieved great results from our clinical trial of DFMO and a new drug called CBL137
  • Professors Glenn Marshall, Michelle Haber and Murray Norris were granted a new translational Program Grant by the CINSW for their research into experimental therapeutics.
  • Endure for a Cure, Diamond Ball and our new Dare the Boss campaign, raised $52,000 in its first year
  • Professor Murray Norris was appointed a Member of the Order of Australia for its outstanding achievements in childhood cancer research
  • Professor Maria Kavallaris was named one of the Australian Financial Review and Westpac's '100 Women of Influence 2015' and appointed to the NHMRC Research Committee
  • Michelle Haber was appointed an inaugural Fellow of he newly established Australian Academy of Health and Medical Sciences.
  • 2015 brought a record level of both research and fundraising income for the Institute.